FDA Person
FDAMichael A. Charles
View detailed information about Michael A. Charles, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 75 inspections of 75 companies, 2016–2025.
Inspections (75)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| January 31, 2025 | Baxter Corporation | VAI | Drug Quality Assurance | #1259651 |
| January 22, 2025 | Element Materials Technology Canada Inc. | Not classified | #1258899 | |
| January 17, 2025 | Eurofins CDMO Alphora Inc. | Not classified | #1258608 | |
| January 16, 2025 | Medline Industries, Inc. | OAI | Drug Quality Assurance | #1258730 |
| December 10, 2024 | Vee Pak, LLC | VAI | Drug Quality Assurance | #1255686 |
| October 25, 2024 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Not classified | #1252840 | |
| October 18, 2024 | Shanghai Desano Bio-Pharmaceutical Co., Ltd. | Not classified | #1252841 | |
| October 11, 2024 | Fujian South Pharmaceutical Co. Ltd | NAI | Drug Quality Assurance | #1255220 |
| July 19, 2024 | Kindos Pharmaceuticals Co., Ltd. | VAI | Drug Quality Assurance | #1244269 |
| July 9, 2024 | Shandong New Time Pharmaceutical Co. Ltd. | VAI | Drug Quality Assurance | #1244268 |
| May 24, 2024 | DECCAN REMEDIES LIMITED | Not classified | #1239427 | |
| May 17, 2024 | Dr. Reddy's Laboratories Ltd. | VAI | Drug Quality Assurance | #1238809 |
| March 20, 2024 | ITM Medical Isotopes GmbH | OAI | New Drug Evaluation | #1231113 |
| January 25, 2024 | BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road) | Not classified | #1227980 | |
| January 16, 2024 | Lexenpharm (Suzhou) Limited | Not classified | #1227981 | |
| November 17, 2023 | Distribuidora Comercial Jafra S.A. de C.V. | VAI | Drug Quality Assurance | #1222907 |
| November 10, 2023 | Nouryon Chemicals, S.A. de C.V. | VAI | Drug Quality Assurance | #1222472 |
| November 3, 2023 | Distribuidora de Alimentos Naturales y Nutricionales S.A de C.V. | VAI | Drug Quality Assurance | #1221868 |
| September 21, 2023 | Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) | VAI | Monitoring of Marketed Animal Drugs, Feed, and Devices | #1218824 |
| September 14, 2023 | Zhejiang Ruibang Laboratories Co., Ltd | VAI | Monitoring of Marketed Animal Drugs, Feed, and Devices | #1218823 |
Documents (53)
- 483 · TAILSTORM HEALTH INC · July 21, 2021
- 483 · Denver Solutions, LLC DBA Leiters Health · October 7, 2021
- 483 · Wiley Chemists Inc. · October 2, 2013
- 483 · College Pharmacy, Inc. · May 28, 2015
- 483 · Apitoria Pharma Private Limited · October 28, 2019
- 483 · Hunter Holmes McGuire Veterans Affairs Medical Center Mammography · March 11, 2015
- 483 · Polpharma Biologics S.A · March 22, 2022
- 483 · KBI Biopharma, Inc. · December 3, 2021
- 483 · Baxter Corporation · January 31, 2025
- 483 · Gland Pharma Limited, Units I+II Pashamylaram Site · November 7, 2019
- 483 · Cephas Life Sciences Private Limited · May 18, 2023
- 483 · Bayer AG · July 27, 2020
- 483 · Medline Industries, Inc. · January 16, 2025
- EIR · RUBICON RESEARCH LIMITED · January 27, 2023
- EIR · Bayer AG · July 27, 2020
- EIR · Infinity Laboratories LLC · October 29, 2015
- 483 · Vee Pak, LLC · December 10, 2024
- EIR · Fujian South Pharmaceutical Co. Ltd · October 11, 2024
- 483 · ST Pharm Co., Ltd. · November 5, 2018
- 483 · Polpharma Biologics S.A
- EIR · Curia New Mexico, LLC · March 20, 2020
- 483 · Xi'an Livingbond Nonwoven Products Corp., Ltd. · January 7, 2019
- 483 · Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. · January 22, 2018
- 483 · TOLMAR, Inc. · February 24, 2020
- 483 · Holiday Labs Mexico, S.A. de C.V. · July 23, 2018
- 483 · L M Manufacturing Limited · February 2, 2022
- 483 · Rohto-Mentholatum (Vietnam) Co., Ltd. · April 6, 2015
- 483 · ITM Medical Isotopes GmbH · March 20, 2024
- 483 · Laboratorios Farmalan, S.A. · March 19, 2019
- 483 · Zhejiang Apeloa Biotechnology Co., Ltd · September 4, 2023
- 483 · Zydus Animal Health and Investments Limited · September 23, 2022
- 483 · Jiangsu Grand Xinyi Pharmaceutical Co., Ltd · September 9, 2019
- 483 · CIRON DRUGS AND PHARMACEUTICALS PVT LTD · September 21, 2022
- 483 · Gland Pharma Limited · May 16, 2019
- 483 · Zhejiang Charioteer Pharmaceutical Co. Ltd. · January 15, 2018
- 483 · Zhejiang Ruibang Laboratories Co., Ltd · September 11, 2023
- 483 · Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) · September 18, 2023
- 483 · ATLAS R&D Inc · September 6, 2018
- 483 · STAQ Pharma, Inc. · September 3, 2020
- 483 · Dr. Reddy's Laboratories Ltd. · May 17, 2024
- EIR · KBI Biopharma, Inc. · December 3, 2021
- 483 · BSO LLC · March 11, 2021
- EIR · Infinity Laboratories LLC · January 7, 2021
- 483 · Shandong New Time Pharmaceutical Co. Ltd. · July 1, 2024
- 483 · Curia New Mexico, LLC · March 20, 2020
- 483 · F. Hoffmann - La Roche Ltd. · August 5, 2022
- 483 · Infinity Laboratories LLC · January 7, 2021
- 483 · Apitoria Pharma Private Limited · October 21, 2019
- 483 · RUBICON RESEARCH LIMITED · January 27, 2023
- 483 · Pharmaplast S.A.E. · November 10, 2022
- 483 · Medline Industries, Inc. · December 8, 2023
- 483 · Kaysersberg Pharmaceuticals SAS · July 19, 2016
- 483 · K.C. Pharmaceuticals, Inc · January 22, 2020
Person Information
Name
Michael A. Charles
Title
Investigator
Role
Regulatory Personnel
ID: f83241f0-ae3b-4535-ac03-e790bbf666ca
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.